Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study
PaperCitations, authors & open-access status
Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2025 year and bronze oa status.
0
Citations
2025
Year
bronze
OA Status